Richard Lehman, BM, BCh, MRCGP

All posts by Richard Lehman, BM, BCh, MRCGP

September 22nd, 2014

Selections from Richard Lehman’s Literature Review: September 22nd

This week’s topics include one-year outcomes after thrombus aspiration for MI, the evaluation and treatment of older patients with hypercholesterolemia, and more.


September 15th, 2014

Selections from Richard Lehman’s Literature Review: September 15th

This week’s topics include prehospital ticagrelor in STEMI, ivabradine in stable CAD without clinical HF, FFR-guided PCI for stable CAD, and more.


September 8th, 2014

Selections from Richard Lehman’s Literature Review: September 8th

This week’s topics include the PARADIGM-HF trial, sham controls in medical-device trials, the efficacy of β blockers in patients with heart failure and atrial fibrillation, and more.


September 1st, 2014

Selections from Richard Lehman’s Literature Review: September 1st

This week’s topics include aortic valve stenosis, presenting the benefits of PCI to patients, and more.


August 18th, 2014

Selections from Richard Lehman’s Literature Review: August 18th

This week’s topics include the three sodium studies from NEJM, the CLARIFY study, and more.


August 11th, 2014

Selections from Richard Lehman’s Literature Review: August 11th

This week’s topics include the effects of intensive glucose control on ischemic heart disease and a meta-analysis of the effects of thrombolysis with alteplase for acute ischemic stroke.


August 4th, 2014

Selections from Richard Lehman’s Literature Review: August 4th

This week’s topic is on the trends in use of ezetimibe after the ENHANCE trial.


July 28th, 2014

Selections from Richard Lehman’s Literature Review: July 28th

This week’s topics include a comparison of catheter-directed thrombolysis plus anticoagulation and anticoagulation alone to treat DVT, several papers on dabigatran and bleeding risk, and more.


July 21st, 2014

Selections from Richard Lehman’s Literature Review: July 21st

This week’s topics include the effects of extended-release niacin with laropiprant in high-risk patients and dual-antiplatelet beyond one year after DES implantation.


July 14th, 2014

Selections from Richard Lehman’s Literature Review: July 14th

This week’s topics are leucocyte telomere length and the risk for CVD, and the association between alcohol and CVD.